Article

Cancer survivors sought for online study

Author(s):

Researchers at Stanford University School of Medicine and The Cancer Research Center of Hawaii are recruiting participants for a study that hopes to improve the lives of cancer survivors."Cancer: Thriving & Surviving" is a six-week, Internet-based workshop to help cancer survivors adjust to life after cancer. Many survivors have unique issues after completing treatment; they may struggle with physical changes, late effects of treatment, emotional concerns, and/or the stress of recurrence.Researchers hope this interactive workshop will help survivors through some of these issues. Each workshop will bring together about 25 survivors and will be facilitated by two trained moderators, one of whom is a cancer survivor. Participants will also have access to an online learning center and discussion boards, and will be asked to log in at their convenience two or three times for a total of about two hours a week during the six-week workshop. This study will assess the effectiveness of this program. The workshop is based on Stanford's "Healthier Living with Chronic Conditions Self-Management Program," which showed in a similar study that participants who developed confidence in managing their own health required fewer medical interventions and were overall healthier. Researchers are looking for about 400 survivors who have completed treatment to participate in this study. For more information and requirements, go to cancersurvivors.stanford.edu or email [email protected].

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content